FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 156 of 156

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
WVE Nasdaq Wave Life Sciences Ltd. 2834
XLO Nasdaq Xilio Therapeutics, Inc. 2834
XRTX Nasdaq XORTX Therapeutics Inc. 2834
XYLO Nasdaq Xylo Technologies Ltd 2834
ZVRA Nasdaq Zevra Therapeutics, Inc. 2834
ZVSA Nasdaq ZyVersa Therapeutics, Inc. 2834
Results 150 through 156 of 156